Sector analysis · US
Health Care: which companies drove growth
The 20 largest Health Care companies by market cap at the end of Q3 2023 (30 Sep 2023), compared with Q2 2023.
The top 20 at Q3 2023
Q3 2023 vs Q2 2023: combined net profit $55.1B (+67%), median EPS +5% (12 of 20 up), market-cap-weighted price −1%. 20 of 20 reported.
| # | Company | Weight | EPS $, base → now | EPS growth | Contribution | Price |
|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | 13.7% | 1.86 → −0.06 | to loss | −4.5 pp | +15% |
| 2 | UnitedHealth Group Incorporated | 12.5% | 5.82 → 6.24 | +7% | +0.9 pp | +5% |
| 3 | Johnson & Johnson | 10.5% | 1.96 → 10.21 | +421% | +52.1 pp | −6% |
| 4 | AbbVie Inc. | 7.1% | 1.14 → 1.00 | −12% | −0.6 pp | +11% |
| 5 | Merck & Co., Inc. | 7.0% | −2.35 → 1.86 | turned profitable | +26.7 pp | −11% |
| 6 | Thermo Fisher Scientific Inc. | 5.2% | 3.51 → 4.42 | +26% | +0.9 pp | −3% |
| 7 | Pfizer Inc. | 5.0% | 0.41 → −0.42 | to loss | −11.8 pp | −8% |
| 8 | Abbott Laboratories | 4.5% | 0.78 → 0.82 | +5% | +0.2 pp | −11% |
| 9 | Danaher Corporation | 4.4% | 1.49 → 1.51 | +1% | +0.1 pp | +3% |
| 10 | Amgen Inc. | 3.9% | 2.57 → 3.22 | +25% | +0.9 pp | +21% |
| 11 | Bristol-Myers Squibb Company | 3.2% | 0.99 → 0.93 | −6% | −0.4 pp | −8% |
| 12 | Medtronic plc | 2.8% | 0.59 → 0.68 | +15% | +0.3 pp | −11% |
| 13 | Stryker Corporation | 2.8% | 1.92 → 1.80 | −6% | −0.1 pp | −10% |
| 14 | Intuitive Surgical, Inc. | 2.8% | 1.18 → 1.16 | −2% | 0.0 pp | −15% |
| 15 | Elevance Health Inc. | 2.7% | 7.79 → 5.45 | −30% | −1.4 pp | −1% |
| 16 | Gilead Sciences, Inc. | 2.5% | 0.83 → 1.73 | +108% | +2.8 pp | −3% |
| 17 | CVS Health Corp. | 2.4% | 1.48 → 1.75 | +18% | +0.9 pp | +1% |
| 18 | Vertex Pharmaceuticals Incorporated | 2.4% | 3.52 → 3.97 | +13% | +0.3 pp | −1% |
| 19 | Regeneron Pharmaceuticals, Inc. | 2.3% | 8.50 → 8.89 | +5% | +0.1 pp | +15% |
| 20 | Cigna Corporation | 2.3% | 4.92 → 4.74 | −4% | −0.1 pp | +2% |
| Sector earnings growth | 100% | +67.2 pp |
Who joined and who left
0 joined and 0 left the top 20 since the previous quarter, as market caps moved.
Joined the top 20 since the previous quarter
Left the top 20 since the previous quarter
EPS growth by company, Q3 2023 to Q2 2026
Each company's EPS growth quarter on quarter, every quarter it was in the top 20.
| Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | to loss | turned profitable | +2% | +32% | −67% | +356% | −37% | +106% | −1% | +19% | +12% | −4% |
| UNH | +7% | −7% | to loss | turned profitable | +43% | −8% | +15% | −45% | −31% | −100% | +62,627% | −12% |
| JNJ | +421% | −84% | −20% | +44% | −42% | +27% | +222% | −50% | −7% | −1% | +2% | +6% |
| ABBV | −12% | −54% | +67% | 0% | +14% | to loss | turned profitable | −26% | −81% | +927% | −62% | +423% |
| MRK | turned profitable | to loss | turned profitable | +14% | −42% | +19% | +36% | −12% | +32% | −49% | to loss | loss, smaller |
| TMO | +26% | −5% | −18% | +17% | +5% | +13% | −17% | +8% | 0% | +22% | −15% | +6% |
| PFE | to loss | loss, bigger | turned profitable | −99% | +18,567% | −91% | +623% | −2% | +22% | to loss | turned profitable | to loss |
| ABT | +5% | +11% | −23% | +6% | +27% | +461% | −86% | +33% | −7% | +9% | −39% | −15% |
| DHR | +1% | −4% | 0% | −16% | −8% | +33% | −11% | −42% | +65% | +32% | −14% | −15% |
| AMGN | +25% | −56% | to loss | turned profitable | +278% | −78% | +176% | −17% | +124% | −59% | +36% | +31% |
| BMY | −6% | −6% | to loss | outside | −28% | −94% | +3,299% | −47% | +69% | −51% | +147% | +24% |
| MDT | +15% | +46% | −51% | +63% | +24% | +2% | −19% | −1% | +32% | −17% | +8% | +19% |
| SYK | −6% | +66% | −31% | +4% | +1% | −35% | +20% | +36% | −3% | −1% | −12% | +71% |
| ISRG | −2% | +46% | −11% | −3% | +7% | +21% | +2% | −6% | +8% | +13% | +3% | +3% |
| ELV | −30% | −33% | +164% | +3% | −56% | −58% | +431% | outside | outside | outside | outside | −16% |
| GILD | +108% | −34% | outside | turned profitable | −22% | +42% | −27% | +50% | +56% | −28% | −7% | to loss |
| CVS | +18% | −9% | −45% | outside | outside | outside | +8% | outside | to loss | turned profitable | 0% | 0% |
| VRTX | +13% | −7% | +13% | to loss | turned profitable | −13% | −29% | +60% | +5% | +11% | −14% | +7% |
| REGN | +5% | +15% | −38% | +98% | −7% | −30% | outside | outside | outside | outside | outside | outside |
| CI | −4% | outside | to loss | turned profitable | outside | +95% | −5% | +18% | outside | outside | outside | outside |